WordNet

any of a large variety of proteins normally present in the body or produced in response to an antigen which it neutralizes, thus producing an immune response

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人におけるクローン病の臨床症状、診断、および予後 clinical manifestations diagnosis and prognosis of crohn disease in adults
2. 乳児、小児、および思春期における炎症性腸疾患の臨床的症状および診断 clinical presentation and diagnosis of inflammatory bowel disease in infants children and adolescents
3. 自己免疫性肝炎：疾患分類 autoimmune hepatitis disease classification
4. 3歳以上の小児における体重増加不良 poor weight gain in children older than two years of age
5. 小児および青年における重症または難治性潰瘍性大腸炎 management of severe or refractory ulcerative colitis in children and adolescents

Systematic review: New serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.

Bonneau J1, Dumestre-Perard C2, Rinaudo-Gaujous M1, Genin C1, Sparrow M3, Roblin X4, Paul S5.
Autoimmunity reviews.Autoimmun Rev.2014 Nov 13. pii: S1568-9972(14)00276-6. doi: 10.1016/j.autrev.2014.11.004. [Epub ahead of print]
Traditionally, IBD diagnosis is based on clinical, radiological, endoscopic, and histological criteria. Biomarkers are needed in cases of uncertain diagnosis, or to predict disease course and therapeutic response. No guideline recommends the detection of antibodies (including ASCA and ANCA) for diag
PMID 25462578

Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.

Ng SC1, Hirai HW, Tsoi KK, Wong SH, Chan FK, Sung JJ, Wu JC.
Journal of gastroenterology and hepatology.J Gastroenterol Hepatol.2014 Sep;29(9):1664-70. doi: 10.1111/jgh.12645.
BACKGROUND AND AIMS: Distinguishing Crohn's disease (CD) from intestinal tuberculosis (ITB) is a clinical challenge. This meta-analysis assessed the clinical usefulness of Interferon-gamma releasing assay (IGRA) and anti-Saccharomyces cerevisiae antibody (ASCA) in the diagnosis of ITB and CD, respec
PMID 24910240

An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease.

Rodrigues IK1, Andrigueti M, de Oliveira Gil ID, de Lucca Schiavon L, de Andrade KR, Pereira IA, de Castro GR, Zimmermann AF, Saporiti LN, Bazzo ML, Neves FS.
Rheumatology international.Rheumatol Int.2014 Aug 14. [Epub ahead of print]
Spondyloarthritis (SpA) is a musculoskeletal inflammatory disease linked with immune responses to intestinal microbiota, and subclinical intestinal ulcerations that are closely related to inflammatory bowel diseases. Helicobacter pylori is a common cause of gastroduodenal ulceration, and anti-Saccha
PMID 25119827